Epetraborole
Tier C — Watch / tradeEpetraborole
Targets：LARS
Indications (approved)：肺脓肿分枝杆菌感染, Renal impairment, Multidrug-resistant tuberculosis, Lung disease, Community-acquired infection, Urinary tract infection, Infection, Breast cancer
Regional status
Synthetic routes & intermediates3 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| EPET-002 | 54314-84-0 | ((3-bromopropoxy)methyl)benzene |
| EPET-015 | 4799-68-2 | 3-(benzyloxy)propan-1-ol |
| EPET-016 | 24677-78-9 | 2,3-dihydroxybenzaldehyde |
| EPET-017 | 1093644-47-3 | 3-(3-(benzyloxy)propoxy)-2-hydroxybenzaldehyde |
| EPET-018 | 1093644-49-5 | 2-(3-(benzyloxy)propoxy)-6-formylphenyl trifluoromethanesulfonate |
| EPET-019 | 1093643-90-3 | 3-(3-(benzyloxy)propoxy)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde |
| EPET-020 | 1093643-35-6 | 7-(3-(benzyloxy)propoxy)-3-(nitromethyl)benzo[c][1,2]oxaborol-1(3H)-ol |
| EPET-021 | 1093643-91-4 | (S)-7-(3-(benzyloxy)propoxy)-3-(nitromethyl)benzo[c][1,2]oxaborol-1(3H)-ol |
| Epetraborole Hydrochloride | 1234563-16-6 | - |
| Code | CAS No. | Intermediate |
|---|---|---|
| EPET-001 | 100-83-4 | 3-hydroxybenzaldehyde |
| EPET-002 | 54314-84-0 | ((3-bromopropoxy)methyl)benzene |
| EPET-003 | 1141781-73-8 | 3-(3-(benzyloxy)propoxy)benzaldehyde |
| EPET-004 | 1338476-04-2 | - |
| EPET-005 | 1338369-02-0 | (S)-1-(3-(3-(benzyloxy)propoxy)phenyl)-2-nitroethanol |
| EPET-006 | 1338369-03-1 | (S)-2-amino-1-(3-(3-(benzyloxy)propoxy)phenyl)ethanol |
| EPET-007 | 1338369-04-2 | (S)-1-(3-(3-(benzyloxy)propoxy)phenyl)-2-(dibenzylamino)ethanol hydrochloride |
| EPET-008 | - | (1S,5S)-3-isopropoxy-1,5-dimethyl-2,4-dioxa-3-borabicyclo[3.1.0]hexane |
| EPET-009 | 1338369-05-3 | (S)-7-(3-(benzyloxy)propoxy)-3-((dibenzylamino)methyl)benzo[c][1,2]oxaborol-1(3H)-ol |
| Epetraborole Hydrochloride | 1234563-16-6 | - |
| Code | CAS No. | Intermediate |
|---|---|---|
| EPET-002 | 54314-84-0 | ((3-bromopropoxy)methyl)benzene |
| EPET-009 | 1338369-05-3 | (S)-7-(3-(benzyloxy)propoxy)-3-((dibenzylamino)methyl)benzo[c][1,2]oxaborol-1(3H)-ol |
| EPET-010 | 121-71-1 | 1-(3-hydroxyphenyl)ethan-1-one |
| EPET-011 | 1338369-06-4 | 1-(3-(3-(benzyloxy)propoxy)phenyl)ethanone |
| EPET-012 | 1338369-07-5 | 1-(3-(3-(benzyloxy)propoxy)phenyl)-2-bromoethanone |
| EPET-013 | 1338369-08-6 | 1-(3-(3-(benzyloxy)propoxy)phenyl)-2-(dibenzylamino)ethanone |
| EPET-014 | 1338369-09-7 | (S)-1-(3-(3-(benzyloxy)propoxy)phenyl)-2-(dibenzylamino)ethanol |
| Epetraborole Hydrochloride | 1234563-16-6 | - |
Frequently asked questions
What are the approved indications of Epetraborole?
Approved indications include: 肺脓肿分枝杆菌感染, Renal impairment, Multidrug-resistant tuberculosis, Lung disease, Community-acquired infection, Urinary tract infection, Infection, Breast cancer.
When does the Epetraborole patent expire?
No public expiry year is available for Epetraborole yet; this page updates once verified.
How many synthesis routes are recorded for Epetraborole?
3 synthesis routes are recorded; the shortest is 6 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Epetraborole intermediates?
All intermediates in Epetraborole routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for Epetraborole intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-19